Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer have?
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer has 141 citations in the OpenAlex counts ScholarIQ stores.
When was Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer published?
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer?
Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer has gold oa status in the ScholarIQ index.
What is the DOI of Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer?
The DOI for Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer is on the source record.
What is the PMID of Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer?
The PMID for Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer is on the source record.
What is the OpenAlex record for Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer?
The OpenAlex for Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer is on the source record.